SLC2A1 and movement disorder: All these mutations, resulting in 50% loss of GLUT1 activity, are identified in patients with the early-onset classical phenotype in combination with intellectual disability and/or movement disorders (patients 2, 3, 7, 14, 18, 21, 27).